Peripheral and alveolar cell transcriptional programs are distinct in acute respiratory distress syndrome

American Journal of Respiratory and Critical Care Medicine

Volumn 197, Issue 4, 2018, Pages 528-532

  Morrell, Eric D ^a,b   Radella, Frank ^a   Manicone, Anne M ^b   Mikacenic, Carmen ^a,b   Stapleton, Renee D ^c   Gharib, Sina A ^a,b   Wurfel, Mark M ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL9 CHEMOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 23P19; INTERLEUKIN 6; OMEGA 3 FATTY ACID; STAT5 PROTEIN; TRANSCRIPTOME; TUMOR NECROSIS FACTOR;

ACUTE LUNG INJURY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC VARIABILITY; GENOME; GENOME-WIDE ASSOCIATION STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; LUNG ALVEOLUS CELL; LUNG ALVEOLUS MACROPHAGE; MALE; NUCLEOTIDE SEQUENCE; PHASE 2 CLINICAL TRIAL (TOPIC); PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RNA ISOLATION; TRANSCRIPTION INITIATION; CLINICAL TRIAL; GENETICS; IMMUNOLOGY; LUNG ALVEOLUS EPITHELIUM CELL; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ALVEOLAR EPITHELIAL CELLS; FEMALE; HUMANS; MALE; RESPIRATORY DISTRESS SYNDROME, ADULT; TRANSCRIPTOME;

EID: 85039755898     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201703-0614LE     Document Type: Letter

References (11)

1. Wang Z, Beach D, Su L, Zhai R, Christiani DC. A genome-wide expression analysis in blood identifies pre-elafin as a biomarker in ARDS. Am J Respir Cell Mol Biol 2008; 38: 724-732.
2. Kangelaris KN, Prakash A, Liu KD, Aouizerat B, Woodruff PG, Erle DJ, et al. Increased expression of neutrophil-related genes in patients with early sepsis-induced ARDS. Am J Physiol Lung Cell Mol Physiol 2015; 308:L1102-L1113.
3. Dolinay T, Kim YS, Howrylak J, Hunninghake GM, An CH, Fredenburgh L, et al. Inflammasome-regulated cytokines are critical mediators of acute lung injury. Am J Respir Crit Care Med 2012; 185:1225-1234.
4. Howrylak JA, Dolinay T, Lucht L, Wang Z, Christiani DC, Sethi JM, et al. Discovery of the gene signature for acute lung injury in patients with sepsis. Physiol Genomics 2009; 37: 133-139.
5. Gharib SA, Watkins TR, Radella F, Nathens AB, Stapleton RD, Wurfel MM. Prognostic transcriptional signatures in acute respiratory distress syndrome [abstract]. Am J Respir Crit Care Med 2014; 189: A5013.
6. Stapleton RD, Martin TR, Weiss NS, Crowley JJ, Gundel SJ, Nathens AB, et al. A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury. Crit Care Med 2011; 39: 1655-1662.
7. Du P, Kibbe WA, Lin SM. lumi: a pipeline for processing Illumina microarray. Bioinformatics 2008; 24:1547-1548.
8. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003; 34:374-378.
9. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102:15545-15550.
10. Donnelly SC, Strieter RM, Kunkel SL, Walz A, Robertson CR, Carter DC, et al. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 1993; 341: 643-647.
11. Goodman RB, Strieter RM, Martin DP, Steinberg KP, Milberg JA, Maunder RJ, et al. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1996; 154:602-611.